Dihydroergotamine nasal and Exenatide extended release
Determining the interaction of Dihydroergotamine nasal and Exenatide extended release and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: exenatide
Brand name: Byetta Prefilled Pen, Bydureon, Bydureon BCise, Bydureon Pen, Bydureon Tray
Synonyms: Exenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine nasal-Exenatide Extended-Release Injection (Bydureon BCise)
- Dihydroergotamine nasal-Exenatide Extended-Release Injection (Bydureon) (Pens)
- Dihydroergotamine nasal-Exenatide Extended-Release Injection (Bydureon) (Trays)
- Dihydroergotamine nasal-Exenatide Injection (Byetta)
- Dihydroergotamine nasal-Exenatide Subcutaneous
- Dihydroergotamine nasal-Exfoliating Moisturizer
- Exenatide extended release-Dihydroergotamine Nasal Spray
- Exenatide extended release-Dilacor XR
- Exenatide extended release-Dilantin
- Exenatide extended release-Dilantin Infatabs
- Exenatide extended release-Dilantin injection
- Exenatide extended release-Dilantin Kapseals